logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Showing 1 - 5 of 5 Items
Showing 1 - 5 of 5 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Conference Material
|
Slide Presentation

Preliminary data on safety and effectiveness of six-month all-oral regimens in patients with rifampicin-resistant tuberculosis in Belarus

Yatskevich N, Hurevich H, Solodovnikova V, Garsevanidze E, Lachenal N,  et al.
2023-06-07 • MSF Scientific Day International 2023
2023-06-07 • MSF Scientific Day International 2023
Conference Material
|
Abstract

Preliminary data on safety and effectiveness of six-month all-oral regimens in patients with rifampicin-resistant tuberculosis in Belarus

Yatskevich N, Hurevich H, Solodovnikova V, Garsevanidze E, Lachenal N,  et al.
2023-06-07 • MSF Scientific Day International 2023
2023-06-07 • MSF Scientific Day International 2023
INTRODUCTION
The total duration of treatment for rifampicin-resistant tuberculosis (RR-TB) in Belarus prior to December 2022 was 18-20 months. The efficacy of treatment with such reg...
Journal Article
|
Research

High time to use rapid tests to detect multidrug resistance in sputum smear-negative tuberculosis in Belarus

Rusovich V, Kumar AMV, Skrahina A, Hurevich H, Astrauko A,  et al.
2014-12-21 • Public Health Action
2014-12-21 • Public Health Action
SETTING
Belarus (Eastern Europe) is facing an epidemic of multidrug-resistant tuberculosis (MDR-TB). In 2012, rapid molecular diagnostics were prioritised for sputum smear-positive p...
Journal Article
|
Research

Poor treatment outcomes among multidrug-resistant tuberculosis patients in Gomel Region, Republic of Belarus

Khaliaukin A, Kumar AMV, Skrahina A, Hurevich H, Rusovich V,  et al.
2014-10-21 • Public Health Action
2014-10-21 • Public Health Action
SETTINGS
Tuberculosis (TB) health facilities in the Gomel Region, Republic of Belarus-settings with a high burden of multidrug-resistant TB (MDR-TB) and human immunodeficiency virus ...
Journal Article
|
Research

Tuberculosis in health care workers in Belarus

Klimuk D, Hurevich H, Harries AD, Babrukevich A, Kremer K,  et al.
2014-10-21 • Public Health Action
2014-10-21 • Public Health Action
SETTING
Tuberculosis (TB), including drug-resistant TB, is a serious problem in Belarus.

OBJECTIVES
To determine the prevalence of TB among health care workers (HCWs) al...